A Study Comparing KB803 and Matched Placebo in Patients With Dystrophic Epidermolysis Bullosa

Clinical trial NCT07016750 · RECRUITING

Trial details

NCT number: NCT07016750
Sponsor: Krystal Biotech, Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Dystrophic Epidermolysis Bullosa DEB - Dystrophic Epidermolysis Bullosa Recessive Dystrophic Epidermolysis Bullosa Dominant Dystrophic Epidermolysis Bullosa

Start date: 2025-06-20
Primary completion: 2026-12-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.